发明名称 |
Pharmaceutical composition comprising Losartan for treating or preventing statin based drug-induced muscle toxicity |
摘要 |
<p>A pharmaceutical composition comprising losartan or a pharmaceutically acceptable salt thereof, which is capable of treating or preventing side effects such as muscle toxicity caused by administering a statin-based lipid-lowering drug, and a pharmaceutical combination composition comprising a statin drug and a losartan drug as active ingredients are provided. The pharmaceutical composition comprising losartan or a pharmaceutically acceptable salt thereof provides an effect on treating or preventing muscle-related side effects caused by administration of a statin drug for treating hyperlipidemia, as well as an intrinsic pharmacological effect for treating or preventing hypertension. When administered along with a statin drug in sequence or co-administered at the same time with the statin drug, the pharmaceutical composition can exhibit an effect of effectively or significantly decreasing or preventing side effects such as muscle toxicity.</p> |
申请公布号 |
EP2604258(A1) |
申请公布日期 |
2013.06.19 |
申请号 |
EP20120161644 |
申请日期 |
2012.03.28 |
申请人 |
HANALL BIOPHARMA CO., LTD. |
发明人 |
KIM, SUNG WUK;CHOE, SEONG CHOON;MIN, CHANG HEE;LEE, SOON IM;KOO, JA SEONG;SUN, SANG OUK;LEE, NA YOUNG |
分类号 |
A61K31/00;A61K31/351;A61K31/402;A61K31/4178;A61P21/00 |
主分类号 |
A61K31/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|